Page last updated: 2024-09-03

fluoroclebopride and clebopride

fluoroclebopride has been researched along with clebopride in 1 studies

Compound Research Comparison

Studies
(fluoroclebopride)
Trials
(fluoroclebopride)
Recent Studies (post-2010)
(fluoroclebopride)
Studies
(clebopride)
Trials
(clebopride)
Recent Studies (post-2010) (clebopride)
11001161711

Protein Interaction Comparison

ProteinTaxonomyfluoroclebopride (IC50)clebopride (IC50)
AcetylcholinesteraseHomo sapiens (human)0.89
D(2) dopamine receptorRattus norvegicus (Norway rat)0.017
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.6026

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boundy, VA; Elder, ST; Evora, PH; Hoffman, PL; Jackson, JR; Luedtke, RR; Mach, RH; Nowak, PA; Scripko, JG; Unsworth, CD1

Other Studies

1 other study(ies) available for fluoroclebopride and clebopride

ArticleYear
18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography.
    Journal of medicinal chemistry, 1993, Nov-12, Volume: 36, Issue:23

    Topics: Animals; Baculoviridae; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Fluorine Radioisotopes; Molecular Structure; Moths; Piperidines; Pituitary Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Recombinant Proteins; Structure-Activity Relationship; Tomography, Emission-Computed; Tumor Cells, Cultured

1993